# Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy

> **NCT02574962** · PHASE2 · WITHDRAWN · sponsor: **Mamatha Pasnoor, MD**

## Conditions studied

- Chronic Inflammatory Demyelinating Polyneuropathy

## Interventions

- **DRUG:** H.P. Acthar® Gel

## Key facts

- **NCT ID:** NCT02574962
- **Lead sponsor:** Mamatha Pasnoor, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-08
- **Primary completion:** 2018-07
- **Final completion:** 2018-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02574962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02574962, "Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02574962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*